BrightSpring posts Q3 2026 earnings beat, lifts FY2026 revenue and EBITDA outlook
BrightSpring Health Services reported third‑quarter 2026 net revenue of $4.213 billion, a 26.4% year‑over‑year increase, and net income from continuing operations of $101 million, more than double the prior year. Adjusted EBITDA rose 42% to $228 million. The company raised its full‑year 2026 revenue guidance to $15.9 billion‑$16.125 billion and adjusted EBITDA guidance to $850 million‑$860 million, while its leverage improved to 1.79×.
Why it matters
The higher revenue and EBITDA forecasts increase the growth expectations for BTSG shareholders and may support a higher valuation. The lower leverage ratio gives the company more financial flexibility for future acquisitions.
Key facts
- 1Q3 2026 net revenue was $4,213 million, up 26.4% YoY. stocktitan.net
- 2Net income from continuing operations was $101 million, versus $38 million in Q3 2025. stocktitan.net
- 3Adjusted EBITDA for the quarter was $228 million, up 42.0% YoY. stocktitan.net
- 4Full‑year 2026 revenue guidance was raised to $15.9 billion‑$16.125 billion. stocktitan.net
- 5Full‑year 2026 adjusted EBITDA guidance was raised to $850 million‑$860 million. stocktitan.net
- 6Leverage ratio was 1.79× as of September 30, down from 2.15× on June 30. stocktitan.net
Summary written by AlphAI AI Desk from 13 of 13 sources. Not investment advice. Figures are as stated by the linked sources.